Pharmaceutical Ingredients (for Research and Experimental Use)
SUBCLASS
Anti-inflammatory Ingredients (for Research and Experimental Use)
COUNTRY OF ORIGIN
Japan
APPLICATION
Tinoridine Hydrochloride: A Nonsteroidal Anti-Inflammatory Agent with a Stabilizing Action on Lysosomes
Tinoridine hydrochloride (Y-3642 hydrochloride) is a nonsteroidal anti-inflammatory and analgesic agent, and also is a potent radical scavenger. It has been reported that tinoridine has a different mechanism of action than common nonsteroidal anti-inflammatory drugs (NSAIDs), which act by inhibiting the cyclooxygenase enzyme and thereby inhibit the synthesis of prostaglandins. The action is attributed to its bio-membrane stabilizing action particularly on the lysosomes which are related to cell or tissue damage at the time of inflammation through the release of hydrolytic enzymes. (The product is for research purpose only.)
P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
RTECS
XJ9088600
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
>98.0%(HPLC)
PHYSICAL FORM
Solid
MWCO (kDa)
352.88
QUALITY CERTIFICATION / COMPLIANCE
Fukaya factory is certified for GMP, ISO14001:2004 (JQA-EM5386) and IQ Net (JP-JQA-EM5386).
APPEARANCE
White to Light yellow powder to crystal
MOLECULAR FORMULA
C17H20N2O2S·HCl
PURITY (HPLC)
min. 98.0 area%
HS NUMBER
2933.99.8290
PURITY / ANALYSIS METHOD
>98.0%(HPLC)
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Ambient
Safety & Storage
Storage Temperature
See product label for specific storage conditions.
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.